Supramolecular nanofiber of indomethacin derivative confers highly cyclooxygenase-2 (COX-2) selectivity and boosts anti-inflammatory efficacy
Journal of Controlled Release · 2023-12 · 364 · 272-282
DOI: 10.1016/j.jconrel.2023.10.030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2023-12. Verfasst von Deqing Lin und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China. Hauptthemen laut MEDLINE: Indomethacin, Nanofibers. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Herein, we report a facile method for converting carboxylate-containing indomethacin (Idm) into a cyclooxygenase-2 (COX-2) selective inhibitor via the amidation of an unnatural peptide sequence (Nal-Nal-Asp). The resulting indomethacin amides (i.e., Idm-Nal-Nal-Asp) have high selectivity for COX-2, and can self-assemble into a one-component supramolecular hydrogel that acts as a 'self-delivery' system for boosting anti-inflammatory efficacy. Self-assembled Idm-Nal-Nal-Asp hydrogel robustly inhibits COX-2 expression in lipopolysaccharide (LPS)-activated Raw 264.7 macrophages while also exhibits superior anti-inflammatory and antioxidant activities via reactive oxygen species (ROS)-related NF-κB and Nrf2/HO-1 pathways. Moreover, a rabbit model of endotoxin-induced uveitis (EIU) reveals that the Idm-Nal-Nal-Asp hydrogel outperforms clinically used 0.1 wt% diclofenac sodium eye drops in terms of in vivo anti-inflammatory efficacy via topical instillation route. As a rational approach to designing and applying COX-2 selective inhibitors, this work presents a simple method for converting non-selective nonsteriodal anti-inflammatory drugs (NSAIDs) into highly selective COX-2 inhibitors that can self-assemble into supramolecular hydrogel for anti-inflammation applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China.
- National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China. Electronic address: jiaqingwang@wmu.edu.cn.
- Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of Zhejiang Province, the First Affiliated Hospital, Wenzhou Medical University, Wenzhou 325027, China. Electronic address: dengjie@wmu.edu.…
- National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China. Electronic address: lixingyi_1984@mail.eye.ac.cn.
Förderung
- Natural Science Foundation of Zhejiang Province
- National Natural Science Foundation of China
Zitieren
APA
Lin, D., Xu, X., Chen, L., Chen, L., Deng, M., Chen, J., Ren, Z., Lei, L., Wang, J., Deng, J., & Li, X. (2023). Supramolecular nanofiber of indomethacin derivative confers highly cyclooxygenase-2 (COX-2) selectivity and boosts anti-inflammatory efficacy. Journal of Controlled Release, 364, 272-282. https://doi.org/10.1016/j.jconrel.2023.10.030
Vancouver
Lin D, Xu X, Chen L, Chen L, Deng M, Chen J, et al. Supramolecular nanofiber of indomethacin derivative confers highly cyclooxygenase-2 (COX-2) selectivity and boosts anti-inflammatory efficacy. Journal of Controlled Release. 2023;364:272-282. doi:10.1016/j.jconrel.2023.10.030
BibTeX
@article{Lin2023,
author = {Lin, Deqing and Xu, Xiaoning and Chen, Lin and Chen, Lei and Deng, Mengyun and Chen, Jinrun and Ren, Zhibin and Lei, Lei and Wang, Jiaqing and Deng, Jie and Li, Xingyi},
title = {Supramolecular nanofiber of indomethacin derivative confers highly cyclooxygenase-2 (COX-2) selectivity and boosts anti-inflammatory efficacy},
journal = {Journal of Controlled Release},
year = {2023},
volume = {364},
pages = {272--282},
doi = {10.1016/j.jconrel.2023.10.030}
}
EUVIMED